EUCTR2009-009320-36-FI进行中（未招募）不适用
A Randomized, Double-Blind, 3-Arm Parallel-Group, 2-Year (104-Week), Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ 28431754 100 mg and JNJ-28431754 300 mg Compared With Glimepiride in the Treatment of Subjects With Type 2 Diabetes Mellitus Not Optimally Controlled on Metformin Monotherapy The CANTATA-SU Trial (CANagliflozin Treatment And Trial Analysis - Sulfonylurea)
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 1,281
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Diagnosis of T2DM;
- •Taking a stable dosage of metformin at screening.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 897
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 384
排除标准
- •· A history of diabetic ketoacidosis, type 1 diabetes mellitus, pancreas or beta-cell transplantation or diabetes secondary to pancreatitis or pancreatectomy;
- •· History of one or more severe hypoglycaemic episodes within 6
- •months prior to screening.
研究者
相似试验
进行中（未招募）
不适用
CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus GlimepirideMedDRA version: 14.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersType 2 Diabetes MellitusEUCTR2009-009320-36-DKJanssen Cilag International NV1,281
进行中（未招募）
1 期
A Randomized, Double-Blind, 3-Arm Parallel-Group, 2-Year (104-Week), Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ 28431754 100 mg and JNJ-28431754 300 mg Compared With Glimepiride in the Treatment of Subjects With Type 2 Diabetes Mellitus Not Optimally Controlled on Metformin Monotherapy The CANTATA-SU Trial (CANagliflozin Treatment And Trial Analysis - Sulfonylurea)MedDRA version: 9.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusType 2 Diabetes MellitusEUCTR2009-009320-36-NOJanssen Cilag International NV
进行中（未招募）
1 期
A Randomized, Double-Blind, 3-Arm Parallel-Group, 2-Year (104-Week), Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ 28431754 100 mg and JNJ-28431754 300 mg Compared With Glimepiride in the Treatment of Subjects With Type 2 Diabetes Mellitus Not Optimally Controlled on Metformin Monotherapy The CANTATA-SU Trial (CANagliflozin Treatment And Trial Analysis - Sulfonylurea)Type 2 Diabetes MellitusEUCTR2009-009320-36-SKJanssen Cilag International NV1,281
进行中（未招募）
不适用
The CANTATA-SU Trial (Canagliflozin Treatment And Trial Analysis-Sulfonylurea)Type 2 Diabetes MellitusEUCTR2009-009320-36-BGJanssen Cilag International NV1,281
已完成
3 期
This study is to check the efficacy, safety, and tolerability of JNJ-28431754 compared with glimepiride in patients with type 2 diabetesCTRI/2010/091/000595Johnson Johnson Pharmaceutical Research Development LLC1,281